Phase Ib of L-NMMA and Pembrolizumab

Clinical trial NCT03236935 · COMPLETED

Trial details

NCT number: NCT03236935
Sponsor: The Methodist Hospital Research Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Malignant Melanoma Head and Neck Squamous Cell Carcinoma Classical Hodgkin Lymphoma Urothelial Carcinoma Bladder DNA Repair-Deficiency Disorders

Start date: 2018-08-27
Primary completion: 2021-10-31
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.